Read More Pharma Industry News Amgen’s Blincyto gains EU approval for consolidation phase treatment in B-ALL Amgen has received European Commission approval for Blincyto (blinatumomab) as part of consolidation therapy in adults with newly… byPallavi MadhirajuJanuary 30, 2025